Measurable residual disease‐guided therapy in acute myeloid leukaemia: Practical insights

Documenti analoghi

• Venetoclax resistance in acute myeloid leukaemia—Clinical and biological insights
  di: Boaz Nachmias, et al.
  Pubblicazione: (2024)
• Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease
  di: Wei‐Ying Jen, et al.
  Pubblicazione: (2024)
• Preclinical activity of resazurin in acute myeloid leukaemia
  di: Trung Quang Ha, et al.
  Pubblicazione: (2024)
• Dynamics of measurable residual disease for risk stratification and guiding allogeneic transplant in acute myeloid leukaemia patients with myelodysplasia‐related mutations in first remission
  di: Ling Jiang, et al.
  Pubblicazione: (2024)
• Sweet's syndrome in acute myeloid leukaemia
  di: Hsu T. Mon, et al.
  Pubblicazione: (2026)